Open Postdoctoral position, faculty mentor Mark Mercola

Applications are invited for a Postdoctoral Research Scientist to work with Professor Mark Mercola developing new investigating new strategies and therapeutic targets for heart failure using iPSC and animal models. This project is part of National Heart Lung and Blood Institute (NHLBI) Catalyze program to develop technologies and transformative platforms supporting cardiovascular drug discovery.
The project is to facilitate disease modeling and drug discovery using patient and CRISPR-engineered human induced pluripotent stem cell (hiPSC) models in combination with high throughput functional genomics.  Projects involve developing computational tools for assessing heart cell function from high throughput physiological datasets that will enable unprecedented large-scale discovery of therapeutic candidates. Postdoctoral fellow will be involved in wet lab as well as dry lab studies.
In addition, postdoctoral fellows will aid in supervising and training of students and technicians. The successful applicant will be expected to present at internal group meetings and will have the opportunity to attend external scientific meetings and draft manuscripts for publication. There will be scope for further research training through courses run at Stanford University and for developing independent research programs with independent funding, for instance NIH or American Heart Association career development awards.
The successful applicant will hold or be near to completion of a relevant PhD degree, and have experience in machine learning and a strong theoretical background in an engineering discipline relevant to cardiac function, such as mechanical engineering or cardiac mechanics. The successful applicant must be strongly motivated with a highly enthusiastic approach to science and good organizational, verbal, communication, and interpersonal skills. They must be able to work both independently and part of a research team. Experience with wet lab techniques and theory, such as hiPSC culture and differentiation and cardiomyocyte physiology, are desirable but not required.
The successful applicant will be based in the new Biomedical Innovation Building centrally located on the Stanford campus and have access to facilities for training and recreation.
Interviews are likely to be held during the first quarter of 2024.